Raymond James Maintains Strong Buy on Radius Global Infr, Lowers Price Target to $21
Raymond James analyst Ric Prentiss maintains Radius Global Infr (NASDAQ:RADI) with a Strong Buy and lowers the price target from $22 to $21.
Radius Global Infr Q2 EPS $(0.20) Up From $(0.50) YoY, Sales $32.57M Miss $34.09M Estimate
Radius Global Infr (NASDAQ:RADI) reported quarterly losses of $(0.20) per share. This is a 60 percent increase over losses of $(0.50) per share from the same period last year. The company reported quarterly sales of
Radius Global Infr’s Earnings Outlook
Radius Global Infr (NASDAQ:RADI) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement.
Analysts estimate that Radius Global Infr will report an earnings per share (EPS) of $-0.46.
Earnings Scheduled For May 9, 2022
Companies Reporting Before The Bell
• Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.
Credit Suisse Maintains Outperform on Radius Global Infr, Lowers Price Target to $23
Credit Suisse analyst Sami Badri maintains Radius Global Infr (NASDAQ:RADI) with a Outperform and lowers the price target from $24 to $23.
Raymond James Maintains Strong Buy on Radius Global Infr, Lowers Price Target to $18
Raymond James analyst Ric Prentiss maintains Radius Global Infr (NASDAQ:RADI) with a Strong Buy and lowers the price target from $21 to $18.
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter.
Berenberg Initiates Coverage On Radius Global Infr with Buy Rating, Announces Price Target of $23
Berenberg analyst Nate Crossett initiates coverage on Radius Global Infr (NASDAQ:RADI) with a Buy rating and announces Price Target of $23.
